Dihydrotachysterol (DHT) is a synthetic vitamin D analog activated in the liver that does not require renal hydroxylation like vitamin D2 (ergocalciferol) and vitamin D3 (cholecalciferol). DHT has a rapid onset of action (2 hours), a shorter half-life, and a greater effect on mineralization of bone salts than does vitamin D.[1]
Clinical data | |
---|---|
AHFS/Drugs.com | Micromedex Detailed Consumer Information |
MedlinePlus | a682335 |
ATC code | |
Identifiers | |
| |
CAS Number | |
PubChem CID | |
DrugBank | |
ChemSpider | |
UNII | |
KEGG | |
ChEBI | |
CompTox Dashboard (EPA) | |
ECHA InfoCard | 100.000.611 |
Chemical and physical data | |
Formula | C28H46O |
Molar mass | 398.675 g·mol−1 |
3D model (JSmol) | |
| |
| |
(verify) |
References
edit- ^ Gagnon R, Ogden GW, Just G, Kaye M (April 1974). "Comparison of dihydrotachysterol and 5,6-trans vitamin D3 on intestinal calcium absorption in patients with chronic renal failure". Canadian Journal of Physiology and Pharmacology. 52 (2): 272–4. doi:10.1139/y74-037. PMID 4365509.